Literature DB >> 2110164

Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer.

R C Hoeben1, R C van der Jagt, F Schoute, N H van Tilburg, M P Verbeet, E Briët, H van Ormondt, A J van der Eb.   

Abstract

We have developed a retroviral-vector system for the transfer and expression of a cloned blood clotting factor VIII cDNA. Since inclusion of the complete cDNA into existing vectors is precluded by its large size, we deleted most codons for the B-domain, which is also excised during in vivo maturation of factor VIII. When inserted into the retroviral vector M5-neoR (Laker, C., Stocking, C., Bergholtz, V., Hess, N., DeLamarter, J. F., and Ostertag, W. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 8458-8462), the sequence was shown to be efficiently expressed in murine fibroblast cell lines, as well as in primary human skin fibroblasts. Upon infection of murine fibroblast cell lines, clones containing only a single copy of the integrated vector-provirus secreted up to 125 milliunits of factor VIII antigen/10(6) cells/day. Equivalent amounts were found in a factor VIII activity assay, which signifies that the factor VIII protein secreted by the infected fibroblasts is fully functional. Primary human skin fibroblasts infected with the vector virus secreted up to 30 milliunits/10(6) cells/day.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2110164

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  Prospects for homologous recombination in human gene therapy.

Authors:  M A Vega
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

Review 2.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

3.  Short-term correction of factor VIII deficiency in a murine model of hemophilia A after delivery of adenovirus murine factor VIII in utero.

Authors:  G S Lipshutz; R Sarkar; L Flebbe-Rehwaldt; H Kazazian; K M Gaensler
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

4.  The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate.

Authors:  F J Fallaux; R C Hoeben; S J Cramer; D J van den Wollenberg; E Briët; H van Ormondt; A J van Der Eb
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

5.  Expression of human blood clotting factor VIII in the mammary gland of transgenic sheep.

Authors:  H Niemann; R Halter; J W Carnwath; D Herrmann; E Lemme; D Paul
Journal:  Transgenic Res       Date:  1999-06       Impact factor: 2.788

6.  Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice.

Authors:  T VandenDriessche; V Vanslembrouck; I Goovaerts; H Zwinnen; M L Vanderhaeghen; D Collen; M K Chuah
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  Inactivation of the Moloney murine leukemia virus long terminal repeat in murine fibroblast cell lines is associated with methylation and dependent on its chromosomal position.

Authors:  R C Hoeben; A A Migchielsen; R C van der Jagt; H van Ormondt; A J van der Eb
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

8.  In vivo production of human factor VII in mice after intrasplenic implantation of primary fibroblasts transfected by receptor-mediated, adenovirus-augmented gene delivery.

Authors:  K Zatloukal; M Cotten; M Berger; W Schmidt; E Wagner; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  Prospects for the use of artificial chromosomes and minichromosome-like episomes in gene therapy.

Authors:  Sara Pérez-Luz; Javier Díaz-Nido
Journal:  J Biomed Biotechnol       Date:  2010-08-24

10.  Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine alpha-lactalbumin regulation sequences.

Authors:  Chuan-Mu Chen; Chih-Hong Wang; Shinn-Chih Wu; Chih-Cheng Lin; Shwu-Hwa Lin; Winston T K Cheng
Journal:  Transgenic Res       Date:  2002-06       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.